Pictet Asset Management (Switzerland)’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $13.3M | Buy |
1,613,141
+556,168
| +53% | +$4.58M | 0.02% | 564 |
|
|
2023
Q1 | $7.66M | Buy |
1,056,973
+808,302
| +325% | +$5.86M | 0.01% | 677 |
|
|
2022
Q4 | $2.21M | Buy |
248,671
+66,485
| +36% | +$590K | ﹤0.01% | 909 |
|
|
2022
Q3 | $2.23M | Buy |
182,186
+49,782
| +38% | +$609K | ﹤0.01% | 901 |
|
|
2022
Q2 | $1.57M | Buy |
132,404
+22,835
| +21% | +$270K | ﹤0.01% | 974 |
|
|
2022
Q1 | $2.08M | Buy |
109,569
+10,058
| +10% | +$191K | ﹤0.01% | 952 |
|
|
2021
Q4 | $2.64M | Hold |
99,511
| – | – | ﹤0.01% | 953 |
|
|
2021
Q3 | $4.09M | Buy |
+99,511
| New | +$4.09M | ﹤0.01% | 876 |
|